iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that it will release financial results for the third quarter and nine-months ended September 30, 2019, before the market open, and host a conference call at 8:30am Eastern Time on Wednesday, October 30, 2019.
NASHUA, N.H., Oct. 24, 2019 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that it will release financial results for the third quarter and nine-months ended September 30, 2019, before the market open, and host a conference call at 8:30am Eastern Time on Wednesday, October 30, 2019.
| Wednesday, October 30th @ 8:30am ET | |
| Domestic: | 877-407-0784 |
| International: | 201-689-8560 |
| Conference ID: | 13695539 |
| Webcast: | http://public.viavid.com/index.php?id=136530 |
About iCAD, Inc.
Headquartered in Nashua, NH, iCAD is a global medical technology leader providing innovative cancer detection and therapy solutions. For more information, visit www.icadmed.com.
Contact:
Media Inquiries:
Jessica Burns, iCAD
+1-201-423-4492
jburns@icadmed.com
Investor Relations:
Jeremy Feffer, LifeSci Advisors
+ 1-212-915-2568
jeremy@lifesciadvisors.com
